Tissue Marker Delivery
Tissue Marker Delivery - Related Videos
05:00
Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery
0 Views •
Cited by 4 •
2010
This article describes the culture of patient tissue slices for gene delivery studies and subsequent analysis of gene expression using IVIS bioluminescence imaging.
02:56
Acufection-Mediated Delivery of Immune-Related Genes into Mouse Skin Tissues
0 Views •
2025
The video demonstrates a method for directly transferring the interleukin-15 encoding plasmid DNA into the skin tissue of an interleukin-15 deficient mouse model through acupuncture using microneedles. These microneedles generate micropunctures in the outermost skin layer, facilitating the absorption and transfection of plasmid DNA into the epidermal cells, including keratinocytes, within the skin tissue.
07:10
Isolation of Histone from Sorghum Leaf Tissue for Top Down Mass Spectrometry Profiling of Potential Epigenetic Markers
0 Views •
Cited by 5 •
2021
The protocol has been developed to effectively extract intact histones from sorghum leaf materials for profiling of histone post-translational modifications that can serve as potential epigenetic markers to aid engineering drought resistant crops.
06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
0 Views •
2025
This study presents a methodology for the delivery of therapeutics into the retina and optic nerves of the adult rat. Additionally, a unique tissue retrieval method is introduced for a top-down en bloc collection of the optic nerve and retina in an adult rat.
09:24
Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
0 Views •
Cited by 2 •
2014
For creation of highly organized structures of complex tissue, one must assemble multiple material and cell types into an integrated composite. This combinatorial design incorporates organ-specific layered cell sheets with two distinct biologically-derived materials containing a strong fibrous matrix base, and endothelial cells for enhancing new vessels formation.
FAQs
Target binding helps retain a detectable label where a molecular feature is present rather than allowing it to distribute uniformly. This can make disease-associated targets easier to distinguish from surrounding tissue. The resulting signal supports identification of cellular features or abnormal regions, while the quality of the interpretation depends on how selectively the label reaches and remains at its intended target.
Local administration places the marker near the tissue of interest, whereas systemic circulation can expose tissues more broadly. A carrier-based strategy adds a mechanism intended to promote selective uptake or accumulation in a defined region. These routes differ in distribution and selectivity, so the choice influences whether delivery emphasizes localized labeling, broader access, or improved targeting.
Controlled distribution concentrates detectable labels in relevant tissue and limits labeling in unrelated regions. Reduced off-target labeling can improve contrast between healthy and abnormal tissue, making the observed signal easier to interpret. These properties are especially important when tissue structure or disease-associated targets must be distinguished without confusing nonspecific accumulation with a meaningful biological finding.
The delivery route, the marker's ability to bind a molecular target, and the use of a carrier that promotes selective uptake all influence where labeling occurs. Accumulation in a defined region can also shape the detectable pattern. Together, these features determine distribution, target retention, signal quality, and the reliability of identifying relevant tissue characteristics.
A medical investigation first selects a detectable label and a delivery strategy suited to the tissue or target of interest. The marker is then introduced through local administration, systemic circulation, or a carrier-based approach. After distribution and any target binding or regional accumulation, the labeled tissue is examined for structural, cellular, or disease-associated signals.
Tissue marker delivery supports diagnostic imaging, histopathology, biomarker validation, and treatment-response assessment. In diagnostic imaging, detectable distribution can help reveal relevant regions. Histopathology can use labeling to examine tissue or cellular features, while biomarker and treatment studies use marker patterns to evaluate disease-associated targets or changes linked to therapeutic response.
The location and strength of detectable labeling can provide information about tissue structure, cellular features, or disease-associated targets. A more selective pattern may improve distinction between healthy and abnormal tissue, while broad or off-target labeling can complicate interpretation. Consequently, delivery performance affects not only detection, but also the confidence of conclusions drawn from the tissue findings.